Soaring Gas Prices: Enough Evidence to Short Auto Stocks?
Chip shortages, supply chain disruptions and depleted inventory levels are just three of the headwinds auto stock investors have been dealing with in recent quarters.
Chip shortages, supply chain disruptions and depleted inventory levels are just three of the headwinds auto stock investors have been dealing with in recent quarters. On Tuesday, Bank of America analyst John Murphy said auto investors can now add skyrocketing gas prices to the mix of problems for the auto industry.
Murphy said the near-term impact of rising gas prices should be minimal for auto stocks, but it may begin to weigh on long-term demand at some point. U.S. gasoline prices are up more than 100% year-over-year to $4.176 per gallon, and Murphy highlighted three ways soaring gas prices are impacting the auto industry.
First, Murphy said higher gas prices may negatively impact the new vehicle sales mix. While gas prices typically don't hurt overall unit demand, consumers may start to choose lower-margin, fuel-efficient passenger cars or even electric vehicles over higher-margin crossovers, trucks and SUVs.
Second, Murphy said the recovery in total U.S. miles driven could be in jeopardy. He said miles driven is the best way to measure vehicle demand, and the average American is on track to spend an additional $727 on gas this year compared to the 2017-2021 average.
Finally, Murphy said gas prices above $5/gal could start to hurt consumer confidence.
China Q1 2022 GDP: five things to watch
China’s economic outlook was already challenging at the beginning of the year, as the effects of President Xi Jinping’s crackdown on property and other high-growth industries rippled through the world’s second-largest economy.
Jamie Dimon Predicted ‘Storm Clouds’ ahead for U.S. Economy Later This Year
The CEO of the biggest U.S. bank by assets said Wednesday that economic growth will continue at least through the second and third quarters of this year, fueled by consumers and businesses flush with cash and paying off debts on time.
Summit Therapeutics(SMMT) Insiders Placed Bullish Bets Worth US$62m in Last 12 Months
Over the last year, a good number of insiders have significantly increased their holdings in Summit Therapeutics Inc. (SMMT).